Summer Sale
50% off Premium Yearly
NYSE:EBS
Emergent BioSolutions (EBS)
Financials 
Technical Analysis 
Instead of buying a single vaccine-making pharma, consider this. They have an established vaccine business and are working on plasma-based treatments for Covid. They also have a big contract manufacturing business of vaccines with JNJ, AZN and Novavax. This has fallen $40 from its August peak. But last night they issued bullish future numbers for this year, and the stock jumped 4.7% today. More upside to come.
- «
- ‹
- 1
- ›
- »
Emergent BioSolutions (EBS) Frequently Asked Questions
What is Emergent BioSolutions stock symbol?
Emergent BioSolutions is a American stock, trading under the symbol EBS (previously EBS-N on Stockchase) on the New York Stock Exchange (EBS). It is usually referred to as NYSE:EBS or EBS
Is Emergent BioSolutions a buy or a sell?
In the last year, no analyst issued a Buy, Sell, or Hold rating on EBS (previously EBS-N on Stockchase) on Stockchase. Read the latest expert commentary for Emergent BioSolutions .
Is Emergent BioSolutions a good investment or a top pick?
Emergent BioSolutions was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Emergent BioSolutions .
Why is Emergent BioSolutions stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Emergent BioSolutions .
Is Emergent BioSolutions worth watching?
Emergent BioSolutions is followed by 14 investors on Stockchase and is a trending stock that is worth watching.
What is Emergent BioSolutions stock price?
On 2026-06-12, Emergent BioSolutions (EBS) stock closed at a price of $8.32.
A disaster. He feels bad for J&J that they ever signed a contract with them.